Lars Ekman
Director at Prothena Corp Public Ltd Co (PRTA)
Lars Ekman has filed 16 insider reports with the SEC since February 2021, as director at Prothena Corp Public Ltd Co (PRTA), director at Amarin Corp PLC\uk (AMRN) and director at Ultragenyx Pharmaceutical Inc. (RARE). Lars Ekman made no open-market purchases or sales in the last 12 months. The latest filing, on May 16, 2026, reports grant or award at Prothena Corp Public Ltd Co (PRTA).
- Filings
- 16
- Companies
- 3
- Bought on market
- None
- Sold on market
- $5.35M
Companies where Lars Ekman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 243 | $5.35M | $8.22 | May 16, 2026 | |||
| Director | $10.57 | Jun 30, 2022 | |||||
| Director | 17,745 | $16.48 | Jun 28, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 15, 2026PRTASEC Form 4 filed by Director Ekman LarsForm 4Grant or award
- May 14, 2025PRTASEC Form 4 filed by Director Ekman LarsForm 4Grant or award
- May 15, 2024PRTASEC Form 4 filed by Ekman LarsForm 4Grant or award
- May 17, 2023PRTASEC Form 4 filed by Ekman LarsForm 4Grant or award
- Jan 3, 2023-$886KPRTASEC Form 4: Ekman Lars exercised 15,834 units of Ordinary Shares at a strike of $6.41 and sold $886,407 worth of Ordinary Shares (15,834 units at $55.98) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 1, 2022-$975KPRTASEC Form 4: Ekman Lars exercised 15,834 units of Ordinary Shares at a strike of $6.41 and sold $975,406 worth of Ordinary Shares (15,834 units at $61.60) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 1, 2022-$996KPRTASEC Form 4: Ekman Lars exercised 15,833 units of Ordinary Shares at a strike of $6.41 and sold $995,658 worth of Ordinary Shares (15,833 units at $62.88) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 3, 2022-$974KPRTASEC Form 4: Ekman Lars exercised 15,833 units of Ordinary Shares at a strike of $6.41 and sold $974,082 worth of Ordinary Shares (15,833 units at $61.52) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 28, 2022-$1.52MPRTASEC Form 4: Ekman Lars exercised 31,666 units of Ordinary Shares at a strike of $6.41 and sold $1,522,818 worth of Ordinary Shares (31,666 units at $48.09) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 27, 2022AMRNSEC Form 4 filed by Ekman LarsForm 4Grant or award
- Jun 24, 2022RARESEC Form 4: Ekman Lars was granted 3,300 shares, increasing direct ownership by 23% to 17,745 unitsForm 4Grant or award
- May 18, 2022PRTASEC Form 4 filed by Ekman LarsForm 4Grant or award
- Jun 24, 2021RARESEC Form 4: Ekman Lars was granted 2,145 units of Common Stock, increasing direct ownership by 17% to 14,445 unitsForm 4Grant or award
- Jun 14, 2021AMRNSEC Form 4 filed by Ekman LarsForm 4Grant or award
- May 19, 2021PRTASEC Form 4 filed by Ekman LarsForm 4Grant or award
- Feb 12, 2021PRTASEC Form 4 filed by Lars EkmanForm 4Grant or awardSale back to the company
Also sits on boards with
Officers and directors who share two or more companies with Lars Ekman.
Compare Lars Ekman with
- Lars Ekman vs Daniel G Welch2 shared
- Lars Ekman vs William P Scully1 shared
- Lars Ekman vs Todd W. Fennell1 shared
- Lars Ekman vs Theodore Alan Huizenga1 shared
- Lars Ekman vs Karah Herdman Parschauer1 shared
- Lars Ekman vs Howard Horn1 shared
Other insiders at the same companies
- William P ScullyPRTA
- Todd W. FennellPRTA
- Theodore Alan HuizengaRARE
- Karah Herdman ParschauerRARE
- Howard HornRARE
- Peter L. FishmanAMRN
- Wagner M. ZagoPRTA
- Karin L WalkerPRTA
- Chad J. SwansonPRTA
- Brandon S. SmithPRTA
- Tran NguyenPRTA
- Gene G. KinneyPRTA
- Anne Evans KingstonPRTA
- Michael John IsaacsPRTA
- Steven B KetchumAMRN
- David Paul KeenanAMRN
Questions about Lars Ekman
- What is Lars Ekman's role at Prothena Corp Public Ltd Co?
- Lars Ekman reports to the SEC as director at Prothena Corp Public Ltd Co (PRTA), according to the latest filing on May 16, 2026. Lars Ekman has also filed as director at Amarin Corp PLC\uk (AMRN) and director at Ultragenyx Pharmaceutical Inc. (RARE).
- How many shares does Lars Ekman own?
- After the latest filing that states it, Lars Ekman directly owned 243 shares of Prothena Corp Public Ltd Co (PRTA) and 17,745 shares of Ultragenyx Pharmaceutical Inc. (RARE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Lars Ekman bought or sold stock recently?
- The most recent open-market sale was on January 3, 2023: sold 15,834 shares of Prothena Corp Public Ltd Co (PRTA) for $886K at an average of $55.98.
- How do I get alerts when Lars Ekman files?
- Follow Lars Ekman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Lars Ekman (SEC CIK 0001376117). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR · Get this as JSON